Clinical Trials · NCT06513962
Triptorelin for the Prevention of Ovarian Damage in Adolescents and Young Adults With Cancer
- Phase
- Phase 3
- Recruitment status
- Recruiting
- Sponsor
- Children's Oncology Group
- Enrollment
- 60
- Start date
- Feb 2025
- Locations
- 206 sites, United States, Canada
- Primary endpoint
- Number of enrollments of newly diagnosed AYA female cancer patients age < 40 years